Oncology Drug Pipeline Analysis Segment Is Witnessing Growth Due To Introduction Of Novel Cancer Treatments And Drugs
Oncology Drug Pipeline analysis The development of new drugs requires hundreds of millions of dollars and takes 15-17 years. Along with assessing the effectiveness of the drug, this analysis examines its safety and likelihood of adverse reactions. The process is extremely costly and is dependent on the successful approval of early-stage trials. Consequently, the process of development and approval is complex and expensive. This is why it is critical to use a reliable tool like Drug Pipeline Analysis to evaluate the future development of a drug. The global oncology drug pipeline analysis is driven by numerous factors, including increasing costs of therapies and the cost of clinical trials. There are two main types of oncology pipelines. The first category includes drugs that are still in development and have significant market potential. The second category consists of cancer-related drugs. The first segment includes products that are already available in...